• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种MPC-BMA共聚物作为紫杉醇纳米转运体的疗效

Efficacy of an MPC-BMA co-polymer as a nanotransporter for paclitaxel.

作者信息

Wada Masahiro, Jinno Hiromitsu, Ueda Masakazu, Ikeda Tadashi, Kitajima Masaki, Konno Tomohiro, Watanabe Junji, Ishihara Kazuhiko

机构信息

Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

出版信息

Anticancer Res. 2007 May-Jun;27(3B):1431-5.

PMID:17595758
Abstract

BACKGROUND

Paclitaxel (PTX) is administered as a solution in polyoxyethylated castor oil (CO) due to its low water solubility, but solvent-induced side-effects may be severe.

MATERIALS AND METHODS

PMB30W is a co-polymer of 2-methacryloyloxyethyl phosphorylcholine (MPC) and butyl methacrylate (BMA). Cytotoxicities of PTX in PMB30W (PTX-PMB30W) were examined in cell culture and in vivo.

RESULTS

PTX-PMB30W and PTX in dimethyl sulfoxide showed similar toxicity in breast cancer cell lines MCF-7, SK-BR-3 and MX-1. Antitumor efficacies of PTX-PMB30W and PTX in CO (PTX-CO) were similar following weekly intraperitoneal administration of 50 mg/kg PTX in nude mice transplanted with MX-1 cells. At 200 mg/kg PTX, all animals died within 1 minute of PTX-CO administration. However, all animals receiving PTX-PBM30W survived. Ulceration occurred following subcutaneous injection of PTX-CO, but injection of PTX-PMB30W did not cause skin changes.

CONCLUSION

Our data suggest that PMB30W can act as an effective PTX nanotransporter.

摘要

背景

由于紫杉醇(PTX)水溶性低,其以聚氧乙烯蓖麻油(CO)溶液形式给药,但溶剂诱导的副作用可能很严重。

材料与方法

PMB30W是2-甲基丙烯酰氧基乙基磷酰胆碱(MPC)和甲基丙烯酸丁酯(BMA)的共聚物。在细胞培养和体内研究了PTX在PMB30W(PTX-PMB30W)中的细胞毒性。

结果

PTX-PMB30W和二甲基亚砜中的PTX在乳腺癌细胞系MCF-7、SK-BR-3和MX-1中显示出相似的毒性。在每周腹腔注射50mg/kg PTX的移植MX-1细胞的裸鼠中,PTX-PMB30W和CO中的PTX(PTX-CO)的抗肿瘤疗效相似。在PTX剂量为200mg/kg时,所有接受PTX-CO给药的动物在1分钟内死亡。然而,所有接受PTX-PBM30W的动物都存活下来。皮下注射PTX-CO后出现溃疡,但注射PTX-PMB30W未引起皮肤变化。

结论

我们的数据表明,PMB30W可作为一种有效的PTX纳米转运体。

相似文献

1
Efficacy of an MPC-BMA co-polymer as a nanotransporter for paclitaxel.一种MPC-BMA共聚物作为紫杉醇纳米转运体的疗效
Anticancer Res. 2007 May-Jun;27(3B):1431-5.
2
Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers.使用水溶性且生物相容的2-甲基丙烯酰氧乙基磷酰胆碱聚合物提高紫杉醇的溶解度。
J Biomed Mater Res A. 2003 May 1;65(2):209-14. doi: 10.1002/jbm.a.10481.
3
Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.将紫杉醇掺入表皮生长因子偶联纳米颗粒中的靶向治疗的开发。
Anticancer Res. 2009 Apr;29(4):1009-14.
4
Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model.聚(2-甲基丙烯酰氧乙基磷酸胆碱-co-正丁基甲基丙烯酸酯)增溶紫杉醇腔内给药治疗原位膀胱癌模型的疗效。
BMC Cancer. 2015 Apr 26;15:317. doi: 10.1186/s12885-015-1338-2.
5
Translymphatic chemotherapy targeting sentinel lymph nodes using a novel phospholipid polymer-Paclitaxel conjugate.经淋巴管化疗靶向前哨淋巴结使用新型磷脂聚合物-紫杉醇偶联物。
Anticancer Res. 2014 Apr;34(4):1751-7.
6
Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.新型生物相容性腹腔内给药系统提高了紫杉醇在人卵巢癌异种移植模型中的耐受性和治疗效果。
Cancer Chemother Pharmacol. 2007 Nov;60(6):907-14. doi: 10.1007/s00280-007-0449-0. Epub 2007 Mar 21.
7
Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.新型自组装聚乙二醇-聚(ε-己内酯-共-三亚甲基碳酸酯)聚合物胶束作为紫杉醇安全有效的递送系统
Eur J Pharm Biopharm. 2009 Oct;73(2):230-8. doi: 10.1016/j.ejpb.2009.06.015. Epub 2009 Jul 3.
8
Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.基于磷酰胆碱的两亲性嵌段共聚物胶束与乙肝表面抗原的前S1结构域偶联,作为一种生物相容性药物递送载体,用于以紫杉醇治疗人类肝细胞癌的选择性靶向。
Int J Cancer. 2009 May 15;124(10):2460-7. doi: 10.1002/ijc.24227.
9
Intraperitoneal administration of paclitaxel solubilized with poly(2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) for peritoneal dissemination of gastric cancer.用聚(2-甲基丙烯酰氧基乙基磷酰胆碱-共-甲基丙烯酸正丁酯)增溶的紫杉醇腹腔内给药用于胃癌腹膜播散
Cancer Sci. 2009 Oct;100(10):1979-85. doi: 10.1111/j.1349-7006.2009.01265.x. Epub 2009 Jun 26.
10
In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth.紫杉醇载药可注射原位形成凝胶的体内抗皮下肿瘤生长作用。
Int J Pharm. 2010 Jun 15;392(1-2):51-6. doi: 10.1016/j.ijpharm.2010.03.033. Epub 2010 Mar 16.

引用本文的文献

1
Solubilization of Paclitaxel by Self-Assembled Amphiphilic Phospholipid-Mimetic Polymers with Varied Hydrophobicity.具有不同疏水性的自组装两亲性磷脂模拟聚合物对紫杉醇的增溶作用。
Polymers (Basel). 2021 Aug 20;13(16):2805. doi: 10.3390/polym13162805.
2
Synthesis and Characterization of PMBN as A Biocompatible Nanopolymer for Bio-Applications.作为用于生物应用的生物相容性纳米聚合物的PMBN的合成与表征
Cell J. 2017 Jul-Sep;19(2):269-277. doi: 10.22074/cellj.2016.4119. Epub 2017 Feb 22.
3
Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model.
聚(2-甲基丙烯酰氧乙基磷酸胆碱-co-正丁基甲基丙烯酸酯)增溶紫杉醇腔内给药治疗原位膀胱癌模型的疗效。
BMC Cancer. 2015 Apr 26;15:317. doi: 10.1186/s12885-015-1338-2.
4
Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation.基于聚(2-恶唑啉)的、对第三代紫杉烷类具有高载药量的胶束:制备、体外和体内评价
J Control Release. 2015 Jun 28;208:67-75. doi: 10.1016/j.jconrel.2015.02.024. Epub 2015 Feb 26.
5
Intraperitoneal administration of paclitaxel solubilized with poly(2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) for peritoneal dissemination of gastric cancer.用聚(2-甲基丙烯酰氧基乙基磷酰胆碱-共-甲基丙烯酸正丁酯)增溶的紫杉醇腹腔内给药用于胃癌腹膜播散
Cancer Sci. 2009 Oct;100(10):1979-85. doi: 10.1111/j.1349-7006.2009.01265.x. Epub 2009 Jun 26.